Next-generation sequencing of antibody transcripts from HIV-1-infected individuals with broadly neutralizing antibodies could provide an efficient means for identifying somatic variants and characterizing their lineages. Here, we used 454 pyrosequencing and identity/divergence grid sampling to analyze heavy-and lightchain sequences from donor N152, the source of the broadly neutralizing antibody 10E8. We identified variants with up to 28% difference in amino acid sequence. Heavy-and light-chain phylogenetic trees of identified 10E8 variants displayed similar architectures, and 10E8 variants reconstituted from matched and unmatched phylogenetic branches displayed significantly lower autoreactivity when matched. To test the generality of phylogenetic pairing, we analyzed donor International AIDS Vaccine Initiative 84, the source of antibodies PGT141-145. Heavy-and light-chain phylogenetic trees of PGT141-145 somatic variants also displayed remarkably similar architectures; in this case, branch pairings could be anchored by known PGT141-145 antibodies. Altogether, our findings suggest that phylogenetic matching of heavy and light chains can provide a means to approximate natural pairings.
Next-generation sequencing of antibody transcripts from HIV-1-infected individuals with broadly neutralizing antibodies could provide an efficient means for identifying somatic variants and characterizing their lineages. Here, we used 454 pyrosequencing and identity/divergence grid sampling to analyze heavy-and lightchain sequences from donor N152, the source of the broadly neutralizing antibody 10E8. We identified variants with up to 28% difference in amino acid sequence. Heavy-and light-chain phylogenetic trees of identified 10E8 variants displayed similar architectures, and 10E8 variants reconstituted from matched and unmatched phylogenetic branches displayed significantly lower autoreactivity when matched. To test the generality of phylogenetic pairing, we analyzed donor International AIDS Vaccine Initiative 84, the source of antibodies PGT141-145. Heavy-and light-chain phylogenetic trees of PGT141-145 somatic variants also displayed remarkably similar architectures; in this case, branch pairings could be anchored by known PGT141-145 antibodies. Altogether, our findings suggest that phylogenetic matching of heavy and light chains can provide a means to approximate natural pairings.
antibody-affinity maturation | antibodyomics | B-cell ontogeny | DNA sequencing | immunological tolerance A pproximately 20% of HIV-1-infected individuals develop antibodies capable of neutralizing diverse isolates of HIV-1 (1-3), and monoclonal antibodies identified from these individuals are revolutionizing our understanding of how the human immune system can recognize highly variable antigens (reviewed in refs. 4 and 5) . Currently, such identification is occurring primarily through the sequencing of antibody heavy and light chains from individually sorted B cells selected by antigen-specific probes (6, 7) or by direct assessment of neutralization from secreted IgG (8) (9) (10) . Highly effective monoclonal neutralizers have now been identified by these techniques from more than 20 donors (reviewed in ref. 11) . Generally, only a few monoclonal antibodies from each donor have been identified, although it is possible to identify substantially more (6, 12) . Indeed, next-generation sequencing technologies (13) (14) (15) (16) (17) (18) seem to offer an efficient means for identifying thousands of somatic variants (19). The massively parallel sequencing that is used by such technologies, however, leads to the loss of information on individual pairings of heavy and light chain and as such, has made it a challenge to discern native antibodies (with naturally paired heavy and light chains) in next-generation sequencing data.
We investigated the identification and functional pairing of heavy and light chains determined by 454 pyrosequencing, which currently allows ∼1,000,000 sequences of 400-500 bp from parallel sequencing on a single chip (19, 20) . Beginning from a single HIV-1 neutralizing antibody (10E8), we identified clonal variants of heavy and light chain that we assessed for function by pairing with the WT 10E8 complementary chain. Phylogenetic trees of heavy and light chains revealed similar branch topologies relative to WT 10E8 sequences, thereby allowing branches of the heavyand light-chain phylogenetic trees to be matched based on their relative distances from 10E8. By assessing a matrix of antibodies reconstituted from matched and mismatched branches for neutralization of HIV-1 and reactivity with self-antigens, we could quantify the use of phylogenetic pairing on function. Lastly, to establish the generality of phylogenetic pairing, we examined B-cell transcripts from donor International AIDS Vaccine Initiative (IAVI) 84, the source of the broadly neutralizing antibodies PGT141-145. As with donor N152, the heavy-and lightchain phylogenetic trees were remarkably similar. Bioinformatics coupled to functional assessment of next-generation sequencingdetermined antibody transcripts can thus furnish a genetic record for clonal families of broadly neutralizing antibodies, including effective HIV-1 neutralizers, with phylogenetic matching of heavy and light chains providing a means to approximate natural pairings.
Results
Next-Generation Sequencing of B-Cell Transcripts from Donor N152.
The broadly neutralizing antibody 10E8 was recently identified in the HIV-1-infected donor N152 (10) . 10E8 recognizes a helixturn-helix in the membrane-proximal external region (MPER) of the transmembrane-spanning HIV-1 gp41 glycoprotein and neutralizes 98% of diverse HIV-1 isolates at a geometric mean IC 50 of 0.22 μg/mL (10) . Unlike other HIV-1-neutralizing antibodies that target the MPER (21), the 10E8 antibody does not react with self-antigens (10) . Its extraordinary breadth and lack of autoreactivity have raised interest in using it as an anti-HIV-1 prophylactic and in understanding its lineage for use as a vaccine template. The heavy chain of antibody 10E8 derives from IgHV3-15 and IgHJ1, has a third complementarity-determining region (CDR H3) of 22 aa, and displays a somatic mutation level of 21% (10) . The light chain of antibody 10E8 derives from IgVL3-19 and IgLJ3, has a CDR L3 of 12 aa, and displays a somatic mutation level of 14% (10) . We performed next-generation sequencing of donor B-cell transcripts using PCR to amplify IgG heavy-chain sequences from the IgHV3 family and amplify IgG light-chain sequences from the IgVL3 family. mRNA from an estimated 5 million peripheral blood mononuclear cells (PBMCs) per sequencing reaction was used for reverse transcription to produce template cDNA (19), and in both cases, we used primers (12) that were upstream from the start of the V-gene leader sequences and downstream from the end of the J chain (Table S1) ; although there should be ∼500,000 B cells per sequencing reaction (10% of PBMCs), the total number of B-cell transcripts is less clear, and oversampling may occur (SI Materials and Methods, Potential Oversampling of B-Cell Transcripts). Overall, Roche 454 pyrosequencing (20) provided 843,084 heavy-chain reads and 1,219,214 light-chain reads for donor N152.
Bioinformatics Identification of 10E8-Related Transcripts. After primary analysis using a previously described bioinformatics pipeline (10, 19) (Figs. S1 and S2), 37,129 full-length heavy-chain sequences were assigned to the IgHV3-15 allelic family, and 54,851 full-length light-chain sequences were assigned to the IgVL3-IgJ3 allelic families. Processed sequences were analyzed for identity to 10E8 and divergence from the unmutated V genes, and their frequencies were displayed on identity/divergence plots (10, 19) ( Fig. 1 A, Left and B, Left). For the heavy chain, several well-separated islands of high identity and about 25% divergence were observed, and for the light chain, a single well-separated island of high identity and about 15% divergence were observed. Grid-based sampling (19) of the high identity-divergence region initially selected 60 heavy-chain sequences and 48 light-chain sequences. After manual inspection to remove erroneous or redundant sequences, 59 heavy chains and 45 light chains remained, which were analyzed for their phylogenetic relationship to 10E8 ( Fig. 1 C and D) .
Functional Assessment of Grid-Selected Transcripts. Grid-selected transcripts were synthesized and reconstituted with their complementary WT 10E8 chain in a 96-well format transient transfection expression system. ELISAs of the expressed 10E8 variants identified 11 heavy chains and 22 light chains, which when paired with the partner WT 10E8 chains bound to a peptide corresponding to the entire MPER of HIV-1 gp41 (Fig. 1 A, Right and B, Right and Fig. S3 ). Expression was then scaled to 250 mL, and all but one light-chain sequence provided sufficient antibody to allow neutralization to be assessed. On a panel of six HIV-1 isolates, up to approximately fivefold increases in neutralization potency relative to 10E8 were observed ( Fig. 1 E and F and Table S2 ).
Maturation Patterns in 10E8-Related Transcripts. Functional 10E8-like heavy chains were derived from three distinct islands on the identity/divergence plots (Fig. 1A) and exhibited sequences and mutational patterns consistent with a common clonal origin ( Fig.  2A) . Mutations clustered in CDR H1 and H3 and also, the first, third, and fourth framework regions (FRs; FR-1, -3, and -4). The most divergent sequence, gVRC-H11 dN152 , had 25 amino acid changes, corresponding to 19.1% difference from the WT 10E8 heavy chain. Often, mutations were distal from the MPERinteracting region but still affected neutralization; for example, in gVRC-H1 dN152 (Fig. 2B ), mutations were observed at the distal portion of the heavy chain variable (VH) domain, but neutralization improved by 6.4 ± 2.7-fold. Functional 10E8-like light chains derived from several regions of the identity/divergence plots, including a single distinct island and several regions overlapping the primary light-chain population (Fig. 1B) . Like heavy chain, functional light chains exhibited mutational patterns consistent with a common clonal origin (Fig. 2C) . Mutations clustered in CDR L1 and L2 regions and all of the FRs. The most divergent sequence, gVRC-L22 dN152 , had 31 amino acid changes, corresponding to 28.4% difference from the WT 10E8 light chain. As with heavy chain, light-chain mutations were often distal from the MPER-contacting region (Fig. 2D) . Unlike the heavy chain, where several variants showed improved potency, most light-chain variants showed reduced neutralization potency.
Phylogeny-Based Pairing of Antibody Heavy and Light Chains. Although functional, the 10E8 variants reconstituted with 10E8 WT complementary chains do not represent natural pairs. As described above, a drawback of the next-generation sequencing approach to antibody identification is that the parallel unlinked sequencing of heavy and light chains loses critical information related to specific pairings of heavy and light chains. We therefore asked whether an evolution-based analysis could provide sufficient information to recapitulate approximate natural pairings. In principle, the maturation/evolution of heavy and light chains should be linked because of their physical association as proteins, the presence of their evolving genes in the same cells subject to the same enzymatic mutation processes, and the requirement for cooperative structural change in response to the same immunogen. Furthermore, the sampling of paired heavy and light chains in a single cDNA library of mRNA population of antibody transcripts should be highly correlated, because they originate from the same cells. In bioinformatics analyses, such coevolution and similarity in sampling should lead to correlations in both topologies and frequencies of corresponding heavy-and lightchain branches of phylogenetic trees.
Phylogenetic analysis of the grid-selected experimentally tested 10E8 heavy and light chains found most of the neutralizing antibodies to populate three branches close to and including template 10E8 ( Fig. 1 C and D) . Branch b1-H for the heavy chain (or b1-L for the light chain) contained 10E8, branch b2-H (b2-L) was the closest branch to b1-H, and branch b3-H (b3-L) was the next closest branch. A single neutralizing sequence (gVRC-H11d N152 ) occupied a more distant branch (b4-H). Because 454 pyrosequencing produces, on average, about five errors per variable antibody domain (10, 22) , we chose the most potent antibody from each branch as representative; therefore, the most functional antibody would likely have the least 454 error-related impairment. We reconstituted 12 antibodies, comprising a complete matrix of heavy-/light-chain pairs from the four heavy-chain branches and the three light-chain branches (Fig. 3A) ; 11 of 12 reconstituted antibodies expressed sufficient levels of IgG to assess neutralization, which was performed on the same panel of six HIV-1 isolates used to test the grid-identified 10E8 variants (Table S3 ). All 11 expressed antibodies were neutralizing. Heavy-and light-chain pairings that matched phylogenetic distance from 10E8 (e.g., b1-H to b1-L, b2-H to b2-L, and b3-H to b3-L) were slightly more potent, on average, than mismatched pairings, but the difference was not statistically significant (Fig. 3B) .
Antibody Pairing and Autoreactivity. We next tested matched and mismatched antibody pairings for reactivity with self antigens (Tables S4 and S5) . Notably, the matched pairings showed significantly lower HEp-2 epithelial cell staining (P = 0.049) (Figs. 3C and Fig. S4 ). Assessment of reactivity with other self antigens, including cardiolipin and a panel of anti-nuclear antigens (23-25), revealed that matched antibodies trended to lower mean reactivity (in 6/6 antibody doses for cardiolipin and 35/36 antibody doses for anti-nuclear antigens) but did not reach statistical significance, likely because mismatched antibodies exhibited a broad range of reactivities ( Fig. S5 and Tables S4 and S5) .
Together, the results show that with 10E8 and donor N152, (i) identity/divergence grid sampling can be used to identify somatic variants, (ii) phylogenetic tree architectures and distances can be used to approximate natural pairings, and (iii) antibodies paired by phylogenetic matching exhibit less autoreactivity. Such reduced autoreactivity is likely related to in vivo selection that natural antibodies undergo (26), observed here within a single clonal lineage. With an antibody like 10E8, which may mechanistically be more prone to autoreactivity than other antibodies (10, 27) , recapitulation of natural antibody-chain pairings may be critical for isolating potential therapeutic antibodies.
Next-Generation Sequencing and Phylogenetic Pairing of B-Cell
Transcripts from Donor IAVI 84. To test the generality of phylogenetic pairing, we performed next-generation sequencing on B-cell transcripts from donor IAVI 84, the source of the broadly neutralizing antibodies PGT141-145 (8) . The clonally related PGT141-145 recognize an N-linked glycan at residue 160 in the V1/V2 region of the HIV-1 gp120 envelope glycoprotein, with residues in strand C of V1/V2 contributing important contacts (28, 29). The most potent of these five antibodies, PGT145, neutralizes ∼80% of diverse HIV-1 isolates at a median IC 50 of 0.29 μg/mL, with PGT141-144 neutralizing 30-50% of HIV-1 at median IC 50 values of 0.21-2.06 μg/mL (8) . The heavy chains of PGT141-145 derive from IgHV1-8, have CDR H3s of 31-32 aa, and display somatic mutation levels of 16-17%, whereas their light chains derive from IgKV2-28, have CDR L3s of 9 aa, and display somatic mutation levels of 13-17% (8) . As with donor N152, we performed 454 pyrosequencing of donor B-cell transcripts using PCR to amplify IgG heavy-chain sequences from the IgHV1 family and amplify IgG light-chain sequences from the IgKV2 family (Table S6 ). In total, 31,324 full-length heavychain sequences with IgHV1-8 origin and 72,397 full-length light-chain sequences with IgKV2-28 origin were identified (Figs. S6 and S7).
To identify heavy or light chains related to the known PGT141-145 antibodies, we performed intradonor phylogenetic analysis (20). Intradonor phylogenetic analysis uses the same procedure as cross-donor phylogenetic analysis, except that the template antibodies are from the same donor (intradonor) rather than added exogenously (cross-donor) (19). In total, this procedure identified 377 heavy-chain members and 481 light-chain members of the PGT141-145 clonal lineage (SI Materials and Methods and Fig. S8 ). We used these sequences to construct phylogenetic trees for the variable domains of heavy and light chains of PGT141-145 (Fig. 4) .
In the heavy-chain dendrogram, antibodies PGT141-144 were positioned on closely related branches, whereas antibody PGT145 was positioned on a separate distant branch (Fig. 4A ). In the lightchain dendrogram, antibodies PGT141-144 were also positioned on closely related branches, whereas antibody PGT145 was also positioned on a separate distant branch (Fig. 4B) , illustrating the expected correlation in evolution between paired heavy and light chains. The numbers of sequences associated with these distinct heavy-and light-chain dendrogram branches were also approximately correlated: the PGT141-144 branch was populated in heavy-and light-chain trees with 1.14 and 1.62 times the number of sequences as the PGT145 branch. The positions of inferred maturation intermediates-at nodal points of heavy-and lightchain phylogenetic trees-also seemed to be correlated, suggestive of similarities throughout the phylogenetic tree architecture.
Discussion
A key aspect of this study is the bioinformatics prediction of heavyand light-chain pairing based on the architectures of phylogenetic trees of heavy-and light-chain sequences within a clonal family. Although natural pairings are lost with current next-generation sequencing, our work suggests that it is possible to approximate them by using topological similarities between antibody heavy-and light-chain phylogenetic trees. We note that branch topology is sensitive to small changes in sequence. In the case of PGT141-145, the five naturally paired antibodies provided anchors with which to pair architectures of heavy and light phylogenetic trees. In the case of 10E8, natural pairings did not seem to yield enhanced neutralization potency relative to the total combinatorial possibilities of all heavy-and light-chain pairings, but other functional properties, such as autoreactivity, seemed to be dependent on matching phylogenetic branches. It will be interesting to see if antibodies are selected in vivo less by differences in HIV-1 Env affinity and neutralization potency than reductions in autoreactivity.
Our results also provide examples of how to populate phylogenetic trees from next-generation sequencing data by either grid searching coupled to antibody synthesis and experimental assessment (which was done to identify 10E8 somatic variants) or an exclusively computational means, such as lineage analysis or phylogenetic sieving (which was done to identify PGT141-145 somatic variants). We previously used similar methods to identify somatic variants for the CD4 binding site antibody VRC-PG04 and the N332-directed antibodies PGT135-137 (19, 20). In the current experiment, grid sampling did not identify a light-chain branch corresponding to the heavy-chain b4-H branch (likely because the b4-L light-chain branch did not form a separate resolved island and the sampling grid did not extend to low enough identity relative to 10E8) (Fig. 1B) . A combination of grid searching, computational analysis, and functional assessment may prove to be a superior means of identifying somatic variants.
Overall, our work shows how-from a single founder sequence, such as for 10E8, or a handful of antibodies, such as for PGT141-145-phylogeny-based bioinformatics analyses of antibody-transcript sequences obtained by next-generation sequencing techniques can both populate a clonal lineage and approximate heavy/ light-chain natural pairings (Figs. 1 C and D and 4). It remains to Measurements were made at antibody concentrations of 25 and 50 μg/mL, as indicated. P value, 0.049 in this case, based on comparison of autoreactivity between matched and mismatched antibodies when both 25-and 50-μg/mL data are used in a two-way ANOVA.
be seen whether such phylogenetic analyses from cross-sectional data are sufficient to reveal the initial recombinant and chronological order of somatic mutations that produced a broad HIV-1-neutralizing antibody. With both 10E8 and PGT141-145, nextgeneration sequencing-inferred lineages extended less than halfway to the initial recombinant, suggesting either substantially greater coverage (e.g., starting with 500 million PBMCs) or longitudinal sampling (e.g., monthly from time of infection) will be required.
Materials and Methods
Appropriate informed consent and institutional review board approval were obtained for the use of Donors N152 and IAVI 84 samples. A cDNA library of B-cell transcripts was prepared from 33 million PBMCs. V gene-specific primers were used to amplify 10E8-related transcripts, which were subjected to 454 pyrosequencing and analyzed with the Antibodyomics1.0 pipeline. The Antibodyomics1.0 pipeline is available upon request from J.Z., L.S., or P.D.K. Similar methods were followed with IAVI 84. Transcripts were synthesized and expressed by transient transfection of 293F cells in either 96-well microplate or 250-mL formats. Functional analysis used ELISA assessment of MPER-peptide binding, HIV-1 neutralization, and autoreactivity assays. Detailed materials and methods and complete references can be found in SI Materials and Methods. (Tables  S1 and S6 ) at 25 μM, 1 μL DNA polymerase, and water to a final volume of 50 μL. The primers each contained the appropriate adaptor sequences (XLR-A or XLR-B) for subsequent 454 pyrosequencing. For the Platinum Taq High Fidelity polymerase, the PCRs were initiated at 95°C for 30 s followed by 25 cycles of 95°C for 30 s, 58°C for 30 s, and 72°C for 1 min and finally, 72°C for 10 min. PCR products of the expected size (∼500 bp) were gelpurified (Qiagen) followed by phenol/chloroform extraction. Final yields of purified DNA were 1.15 μg for the heavy chain and 0.9 μg for the light chain. For donor IAVI 84, a similar sample preparation procedure was adopted, except for the primers (listed in Table S6 ).
454 Library Preparation and Pyrosequencing. The 454 pyrosequencing was carried out as described (3, 4) . Briefly, PCR products were quantified using Qubit (Life Technologies). Library concentrations were determined using the KAPA Biosystems qPCR System, with 454 standards provided in the KAPA system; 454 pyrosequencing of the PCR products was performed on a GS FLX sequencing instrument (Roche-454 Life Sciences) using the manufacturer's suggested methods and reagents. Initial image collection was performed on the GS FLX instrument, and subsequent signal processing, quality filtering, and generation of nucleotide sequence and quality scores were performed on an off-instrument linux cluster using 454 application software (version 2.5.3). The amplicon quality filtering parameters were adjusted based on the manufacturer's recommendations (Application Brief No. 001-2010; Roche-454 Life Sciences). Quality scores were assigned to each nucleotide using methodologies incorporated into the 454 application software to convert flowgram intensity values to Phredbased quality scores as described. The quality of each run was assessed by analysis of internal control sequences included in the 454 sequencing reagents. Reports were generated for each region of the PicoTiterPlate for both the internal controls and samples.
Primary Bioinformatics Analysis of 454 Pyrosequencing-Determined
Antibodyomes. The bioinformatics pipeline developed in our previous studies (3, 4) was used to process the 454 pyrosequencing data and calculate parameters required for antibodyome analysis.
The pipeline processing consists of five steps. Starting with a 454 pyrosequencing-determined antibodyome, each sequence read was (i) reformatted and labeled with a unique index number; (ii) assigned to variable (V), diverse (D), and joining (J) gene families and alleles using an in-house implementation of IgBLAST (www.ncbi.nlm.nih.gov/igblast/) to search precompiled heavyand light-chain (λ and κ) germ-line gene libraries (sequences with E value > 10 −3 for V gene assignment were rejected); (iii) subjected to a template-based error correction scheme, where 454 homopolymer errors in V, D (heavy chain only), and J regions were detected and corrected based on the alignment to respective germ-line sequence (D or J gene was corrected only when the gene assignment was reliable, which was indicated by an E value < 10 ); (iv) compared with a set of template antibody sequences at both nucleotide and amino acid levels using a global alignment module in CLUSTALW2 (5), providing the basis for identity/divergence analysis ( Fig. 1 A and B and Fig. S8) ; (v) subjected to a multiple sequence alignment-based scheme to determine the third complementarity-determining region (CDR H3 or L3), which was further compared with a set of template CDR H3 or L3 sequences at nucleotide level, and determine the sequence boundary of variable domain. In this scheme, the multiple alignments of representative germ-line V (truncated before the CDR3 region) and J genes (truncated after the CDR3 region) were precalculated and used for determination of variable domain sequences. For example, in the heavy-chain analysis, a 454 pyrosequencing-derived sequence would be added to the multiple alignment of 52 representative immunoglobulin heavy chain variable (IgHV) genes (truncated at the second amino acid after a cysteine near the C terminus) and 6 representative immunoglobulin heavy chain joining (IgHJ) genes (truncated before the WGXG motif) to determine the CDR H3 region, which is between the last column of aligned V genes and first column of aligned J regions, as well as the variable domain, which is between the first column of aligned V genes and last column of aligned J genes. Only full-length variable domain sequences were retained in the output dataset.
Because of the similarity between closely related germ-line genes, there is potential ambiguity in germ-line gene assignment. However, our analysis suggested that the assignment for 10E8, PGT141-145, and their variants was sufficiently accurate. For example, both IMGT (6) and IgBLAST (http://www.ncbi.nlm. nih.gov/igblast/) yielded the same result for 10E8 heavy chain as reported recently (1) . Specifically, the top three assignments from IgBLAST were alleles of the IgHV3-15 gene: 3-15*05, 3-15*07, and 3-15*01, respectively. The best-scored assignment was obtained for IgHV3-15*05, with an E value of 7 × 10 −73
and 265 nt matched. Also note that all sequences in the assigned germ-line gene family, irrespective of alleles, were used for identity/ divergence grid analysis and phylogenetic analysis.
Identity/Divergence Grid Analysis of Donor N152 Antibodyome. As shown in Fig. 1 A and B , the frequency of 454 pyrosequencingdetermined sequences was plotted as a function of divergence from germ-line V-gene origin (x axis) and identity from 10E8 (y axis), both calculated at the nucleotide level. Given the identity/ divergence plots, a grid-based search procedure was used to identify representative sequences for experimental verification and heavy-and light-chain pairing. For the heavy-chain antibodyome, a 10 × 20 grid was placed over the quadrant defined by a divergence range of 10-30% and an identity range of 60-100%. For the light-chain antibodyome, an identity range of 80-100% was used in the analysis. The sequences within each square of the grid were subjected to a clustering calculation using BLASTClust (7), with a 90% sequence identity cutoff. Instead of picking a sequence randomly from the largest cluster (3), a set of candidate sequences were selected based on the following criteria: (i) the number of sequences selected from each cluster is proportional to the cluster size, ∼log 10 (N) + 1, where N is the total number of sequences within the cluster, and (ii) selection priority will be given to those sequences without errors at the amino acid level and with correct sequence motifs preceding and succeeding the CDR3-the cysteine and WGXG (for heavy chain) or FGXG (for light chain). For each square of the grid, a single sequence was selected from the candidates based on the manual inspection and deposited in a separate dataset. An initial set of 60 heavy chains and 48 light chains was obtained using this approach. After additional screening (e.g., removal of erroneous/redundant sequences), 59 heavy chains and 45 light chains remained in the final dataset.
Identity/Divergence Analysis and Lineage Analysis of Donor IAVI 84
Antibodyome. As shown in Fig. S8 A, panel 1 and B, panel 1, the frequency of 454 pyrosequencing-determined sequences of IgHV1-8 or IgKV2-28 origin was plotted as a function of divergence from germ-line V-gene origin (x axis) and identity from PGT145 (y axis), both calculated at the nucleotide level. Using CDR H3 or L3 as signature, 64 heavy chains and 81 light chains were identified to be members of PGT141-145 lineage (Fig. S8 A,  panel 2 and B, panel 2) . The intradonor phylogenetic analysis developed in our previous study (4) was used to infer somatic variants of PGT141-145. In this analysis, with IAVI 84 sequences and PGT141-145 template sequences, 326 heavy chains and 493 light chains were identified. Analysis of sequences for errors (e.g., stop codons, J segments with low sequence identity to known J chains, or PCR-switched C termini) identified 3 and 12 outliers in heavy and light chains, respectively, which were removed from the clonal lineage. When plotted on the 2D divergence/identity plots, the identified sequences showed greater than 75% identity to the template sequences (Fig. S8 A, panel  3 and B, panel 3) . Note that the sequences from CDR H3/L3 matching were a subset of the intradonor-identified sequences. Because the CDR H3 and CDR L3 potentially provide signatures for the clonal lineage, we next identified all heavy-and light-chain sequences that had identical CDR H3 or CDR L3 to the 323 heavy-and 481 light-chain template sequences. These analyses provided an additional 54 heavy-and 14,566 light-chain sequences, with divergences ranging between 18% and 26% for the heavy chain and between 0% and 18% for the light chain (Fig. S8 A, panel 4 and B, panel 4) . The very high number of light-chain sequences with identical CDR L3s suggested that CDR L3 analysis did not provide a signature specific to a single clonal lineage. Thus, only light chains selected by intradonor analysis (481) were used for phylogenetic pairing with intradonor-selected heavy chains (323) and their somatic relatives with identical CDR H3s (54), a total of 377 sequences.
Phylogenetic Pairing of Heavy and Light Chains. For donor N152, the variable domain sequence of 10E8, 10E8 H, or 10E8 L and its respective germ-line gene, IgHV3-15*05 or IgLV3-19*01, were added to the sequences obtained from the identity/divergence grid analysis to produce multiple sequence alignment using CLUSTALW2 (5). For donor IAVI 84, the variable domain sequences of PGT141-145, heavy or light, and their respective germ-line gene, IgHV1-8*01 or IgKV2-28*01, were added to the sequences obtained from clonal lineage analysis to produce multiple sequence alignment using CLUSTALW2 (5). The alignment was then provided as input to construct a phylogenetic tree using DNA Maximum Likelihood program with Molecular Clock (http://cmgm.stanford.edu/phylip/dnamlk.html) in the PHYLIP package v3.69 (http://evolution.genetics.washington.edu/phylip. html). The calculation was done with default parameters (empirical base frequencies, the transitions to transversions ratio of 2.0, and the overall base substitution model as A 0.24, C 0.28, G 0.27, and T 0.21). The output unrooted tree was visualized using Dendroscope (8) , ordered to ladderize right, and rooted by germline gene. The heavy-and light-chain phylogenetic trees are shown in Fig. 1 C and D for donor N152 and Fig. 4 for donor IAVI 84. The pairing of heavy and light chains was based on the similarity between topologies of phylogenetic branches of the heavy and light chains and in the case of 10E8 also on phylogenetic distance from the mature heavy and light chains. The antibodies resulting from phylogenetic pairing were validated experimentally for donor N152, as described in the following sections.
Transient Transfection Expression of Identified Ig Chains in 96-Well
Microplates. A high-throughput technique was applied to screen the heavy and light chains obtained from identity/divergence grid analysis of 454 pyrosequencing-determined donor N152 antibodyomes. Specifically, each heavy or light chain was cloned, paired with WT 10E8 light or heavy chain, and expressed in HEK293T cells as follows. HEK 293T cells (Invitrogen) were incubated with growth medium (DMEM with 10% (vol/vol) FBS and 1% (vol/vol) streptomycin-penicillin) (Invitrogen) at 37°C and 5% CO 2 until the cells reached logarithmic physiological growth; 24 h before DNA-transient transfection, 100 μL physiologically growing cells were seeded in each well of a 96-well microplate at a density of 2.0 × 10 5 cells/mL in expression medium (DMEM supplemented with 10% Ultra-Low IgG FBS and 1× nonessential amino acids) (Invitrogen) and incubated at 37°C and 5% CO 2 for 20 h. Two hours before transfection, 100 μL spent medium from each well were replaced with 65 μL fresh medium. DNA-TrueFect-Max complexes were prepared by mixing 0.2 μg DNA (0.1 μg heavy-chain plasmid combined with 0.1 μg lightchain plasmid) in 10 μL Opti-MEM transfection medium (Invitrogen) with 0.5 μL TrueFect-Max (United BioSystems) in 10 μL Opti-MEM and incubating for 15 min before transfection; 20 μL complex were added into each well, and the 96-well plate was incubated at 37°C and 5% CO 2 . At day 1 posttransfection, 10 μL enriched medium (High-Glucose DMEM plus 25% Ultra-Low IgG FBS, 2× nonessential amino acids, 2× glutamine, 10 mM butyrate) were added to each well, and on days 2 and 3 posttransfection, 5 μL enriched medium were added into each well. On days 3-5 posttransfection, the culture was exposed to oxygen in the sterilized air one time per day. After day 5 posttransfection, the binding activity and titer of IgG in each well supernatant were characterized by ELISA using gp41 immunogen peptide as the coating antigen.
Expression and Purification of Paired Antibody Heavy and Light
Chains. For 10E8-like antibodies used for neutralization and autoreactivity assays, protein production was similar to what has been described before (3, 4) . Briefly, the antibody sequences were synthesized (Blue Heron) and cloned into the pVRC8400 expression vector containing the constant regions of IgG1. Full-length IgGs expressed from 250 mL transient transfection cultures of 293F cells were purified using a protein-A column (Pierce).
ELISA Assays. Supernatants from high-throughput expression of the 59 10E8 heavy-chain variants and 45 10E8 light-chain variants (paired with their WT counterparts) were tested for IgG expression and binding to a gp41 MPER peptide by ELISA. For IgG expression, Maxisorp plates (Nunc) were coated overnight at 4°C with a goat IgG specific for the human λ-light chain at 100 ng/well in PBS. For MPER reactivity, neutravidin-coated plates (Pierce) were incubated overnight at 4°C with a biotinylated MPER peptide (RRRNEQELLELDKWASLWNWFDITNWLWYIRRKKbiotin; American Peptide) at 325 nM in PBS. The following day, plates were washed five times with wash buffer composed of PBS supplemented with 0.05% Tween 20 and blocked for 1-2 h at 25°C in blocking buffer composed of PBS supplemented with 2% dry-milk powder (Difco), 5% heat-inactivated FBS, and 0.05% Tween 20. After a wash step, 100 μL 1:10 dilution supernatants (in blocking buffer) were added to the wells and incubated for 1 h at 25°C; 100 μL recombinant 10E8 controls were added at fivefold serial dilutions in blocking buffer starting at a concentration of 5 μg/mL. Plates were washed and then incubated for 1 h at 25°C with an anti-human IgG secondary antibody (Jackson Labs) at a 1:10,000 dilution in blocking buffer. After a wash step, 100 μL colorometric 3,3′,5,5′-tetramethylbenzidine peroxidase enzyme immunoassay substrate (Bio-Rad) were added to each well. The reactions were stopped with 100 μL 0.1 N H 2 SO 4 per well. OD was read on a microplate reader at 450 nm using Softmax software (Molecular Devices). Variants paired with their 10E8 mature counterparts that displayed MPER binding at OD at 450 nm readings >1 were deemed positive.
HIV-1 Neutralization Assays. Neutralization was measured using HIV-1 Env-pseudoviruses to infect TZM-bl (JC53-bl; NIH AIDS Reasearch and Reference Reagent Program) cells as described (3, 4) . Neutralization curves were fit by nonlinear regression using a five-parameter hill slope equation as described. The IC 50 values were reported as the antibody concentrations required to inhibit infection by 50%.
Autoreactivity Assays. Reactivity to HIV-1 negative human epithelial (HEp-2) cells was determined by indirect immunofluorescence on slides using Evans Blue as a counterstain and FITCconjugated goat anti-human IgG (Zeus Scientific) (9) . Slides were photographed on a Nikon Optiphot fluorescence microscope. Regarding Fig. 3B , kodachrome slides were taken of each monoclonal antibody binding to HEp-2 cells at a 10-s exposure, and the slides were scanned into digital format. The Luminex AtheNA Multi-Lyte antinuclear autoantigen test (Wampole Laboratories) was used to test for monoclonal antibody reactivity to Sjögren's syndrome A (SSA)/Ro, Sjögren syndrome B antigen (SS-B)/La, Sm, ribonucleoprotein, Jo-1, dsDNA, centromere B, and histone and was performed as per the manufacturer's specifications as previously described (9) . Monoclonal antibody concentrations assayed were 50, 25, 12.5, and 6.25 μg/mL; 10 mL each concentration were incubated with the luminex fluorescent beads, and the test was performed per the manufacturer's specifications. Reactivity with cardiolipin was tested with luminex technology as well using the anticardiolipin (ACL) assay (Wampole Laboratories).
Structural Threading. Swiss model software (10) (http://swissmodel. expasy.org/) was used to thread the sequences of the most potent heavy-and light-chain variants of each branch (based on median IC 50 values) onto the WT 10E8 structure in complex with the gp41 MPER (Protein Data Bank ID code 4G6F). Default parameters were used in the model building process without additional optimization of the structural models obtained.
analyzed with the use of Prism 5.0 (Graphpad). In both cases, a repeated measures two-way ANOVA was performed. IC 50 values against all six viral isolates were used in the analysis. In the case of the HEp-2 cell staining comparison, antibody doses at both 25 and 50 μg/mL were used. For comparison of ACL ELISA, a repeated measures two-way ANOVA was performed at antibody doses of 100, 33.33, 11.11, 3.7, 1.23, and 0.41 μg/mL. For comparison of Athena autoantigen reactivity, a repeated measures two-way ANOVA was computed for each of nine different targets at antibody doses of 50, 25, 12.5, and 6.25 μg/mL (Table S5) .
Potential Oversampling of B-Cell Transcripts. An important point that needs to be considered is how the number of reads obtained by 454 sequencing compares with the number of antibody transcripts present in the donor samples analyzed. If the number of 454 sequence reads obtained was substantially larger than the number of transcripts in a given sample, it would lead to oversampling. Furthermore, because 454 pyrosequencing introduces errors at a rate of ∼1-2 per 100 nt (4, 11), if oversampling was indeed present, sequencing errors could make duplicate reads of the same transcript appear to be different. It is likely that such oversampled duplicates, caused by the relatively low error rate, would be assigned as somatic variants of one another. To understand this issue and its potential impact on the work that we describe here, it is critical to estimate the total number of antibody transcripts in the donor PBMC samples and compare these estimates with the number of 454 reads to determine whether there is a significant likelihood of oversampling.
The potential for enrichment of a given antibody transcript by functional selection could play a significant role in transcript number. Thus, we have taken two approaches to estimate total numbers of transcripts: (i) presuming no enrichment caused by selection or conversely, (ii) presuming that functional selection enriches the fraction of relevant transcripts. i) Assuming that there is no enrichment caused by selection, then starting with ∼500,000 B cells, we estimate that at least ∼1/4 of these cells will be heavy chain variable-3 (VH-3) lineage or ∼125,000 cells (12, 13). If we assume that ∼100 mRNA transcripts are present per cell, this number of transcripts would correspond to ∼12.5 million VH-3 transcripts in the sample. With such a large number of transcripts and only ∼530,000 VH-3 originated sequences found in the 454 dataset, it is unlikely that oversampling would occur. However, ∼100 mRNA transcripts might be an overestimate. Given the error rate of 454 pyrosequencing (4, 11) , for the current case, we estimate that ∼20% of the reads (106,000) are unique reads. This number is very close to our initial estimate of ∼125,000 VH-3 lineage B cells, arguing against significant oversampling. ii) However, our final analysis finds ∼80 unique heavy chains and ∼30 unique light chains in this dataset that are somatically related to 10E8. Are these variants a result of oversampling? One way to assess this question is to examine these numbers as a percentage of overall sequencing reads. For the heavy chain, 10E8 variants represent ∼0.01% of total reads, and for the light chains, they represent ∼0.003% of total reads. If these percentages are compared with donor IAVI 74 reported in our earlier paper, for which VRC-PG04 relatives represented ∼0.5% of total reads, donor N152 is on the low end (3). In immunization studies, shown by Reddy et al. (14) , a single lineage can reach ∼10-11% for the heavy chain, implying significant enrichment because of selection under some conditions (14) . In light of these observations for other datasets, our results for donor N152, with ∼80 distinct heavy chains and ∼30 distinct light chains, seem to be relatively ordinary, and they are in near agreement with the numerical approximations outlined above, which again argues against a significant oversampling problem. iii) Finally, it is important to note that, even if sequencing errors did lead to oversampling, its effects would have limited impact on the main conclusions of our study. Because 454 sequencing generates sequences with ∼1-2% error (4, 11) , such errors would impact the leaves of the phylogenetic tree, but they are too small to alter the overall branch topology relevant to pairing heavy and light chains. Because these branches differ by ∼10% or more in sequence (up to 30%), such an error rate would not alter conclusions related to phylogenetic pairing, which is the major focus of the current study. Thus, even if oversampling were a significant issue and although in such a case, estimates of the number of unique B cells would be altered, the primary conclusions related to phylogenetic pairing would stand unaffected. assay for overall IgG expression, the same supernatants were tested for binding to an anti-human λ-light-chain antibody (green bars; B, heavy chain; D, light chain). WT antibodies 10E8 and VRC01 were expressed and tested in parallel (red bars), and recombinant 10E8 was used as an ELISA control (blue bars; fivefold serial dilutions starting at a concentration of 5 μg/mL). Lack of binding to MPER could be a result of several factors, including distinct clonal lineage and poor pairing with mature 10E8 counterpart. All light-chain variants that bound MPER possessed arginines at positions 91 and 95b, which contact the MPER in the crystal structure (Protein Data Bank ID code 4G6F). Of the remaining expressed light-chain variants that were nonreactive with MPER, 11 variants had CDR L3s with deletions or significant sequence differences with mature 10E8 CDR L3, suggesting the possibility that they belong to a distinct clonal lineage, including 3 variants that lack arginine at position 91, which is required for binding. Matched and mismatched groups were compared at all antibody doses for reactivity with each of nine autoantigens (listed in Table S5 ) using a repeated measures two-way ANOVA. For all antibody doses tested (6/6), matched variants exhibited lower mean reactivities with nuclear antigens than mismatched variants, though no differences were statistically significant. In all cases, blue is used for phylogenetically matched variants (circles), and red is used for phylogenetically mismatched variants (squares). Horizontal bars are the respective means of each group and colored accordingly. . In this step, given a sequence read, V(D)J components were determined using a local implementation of IgBLAST. Sequences with an E value of 1.0 × 10 −3 or greater for V-gene assignment were removed. Note that 39,734 sequences were found to be of IgHV1-8*01 allelic origin, the germ-line gene of PGT141-145 antibody heavy chains. (C) Correlation between number of gaps and sequence quality improvement measured by the increase of sequence identity to germ-line V gene after correction (step 3). The correlation coefficient was calculated to be 0.69, and the P value was less than 0.0001. (D) Sequence quality improvement distribution (step 3) with an average improvement of 17.4%. In this step, a template-based correction procedure was applied to correct homopolymer errors in V, D, and J genes. Note that D and J genes were subjected to this correction procedure only when their E values for germ-line assignment were significant (1.0 × 10 −3 or lower). The identities to PGT141-145 heavy chains were calculated in step 4, and the exact boundaries for variable domain and CDR H3 region were calculated in step 5. . In this step, given a sequence read, V and J components were determined using a local implementation of IgBLAST. Sequences with an E value of 1.0 × 10 −3 or greater for V-gene assignment were removed. Note that 77,362 sequences were found to be of IgKV2-28*01 allelic origin, the germ-line gene of PGT141-145 antibody light chains. However, because of the high similarity between IgKV2-28*01 and IgKV2D-28*01, all sequences were misassigned to IgKV2D-28*01. (C) Correlation between number of gaps and sequence quality improvement measured by the increase of sequence identity to germ-line V gene after correction (step 3). The correlation coefficient was calculated to be 0.72, and the P value was less than 0.0001. (D) Sequence quality improvement distribution (step 3) with an average improvement of 17.5%. In this step, a template-based correction procedure was applied to correct homopolymer errors in V and J genes. Note that the J gene was subjected to this correction procedure only when its E value for germ-line assignment was significant (1.0 × 10 −3 or lower). The identities to PGT141-145 light chains were calculated in step 4, and the exact boundaries for variable domain and CDR L3 region were calculated in step 5. (Fig. 4) . Heavy-and light-chain variants are color-coded according to the phylogenetic segregation in Fig. 1 C and D (for heavy chains, b4-H variants are shown in purple, b3-H variants are shown in blue, b2-H variants are shown in green, and b1-H variants are shown in orange, whereas for light chains, b3-L variants are shown in blue, b2-L variants are shown variants in green, and b1-L variants are shown in orange). Sequences are displayed in the same order as they appear in the phylogenetic trees. HC, heavy chain; LC, light chain. *Neutralization results are color-coded as follows: light red, IC 50 ≤ 0.05 μg/mL; light brown, 0.05 μg/mL < IC 50 ≤ 0.5 μg/mL; light yellow, 0.5 μg/mL < IC 50 ≤ 5 μg/mL; light green, IC 50 > 5 μg/mL. Heavy-and light-chain variants are color-coded according to the phylogenetic segregation in Fig. 1  C and D (for heavy chains, b4 -H variants are shown in purple, b3-H variants are shown in blue, b2-H variants are shown in green, and b1-H variants are shown in orange, whereas for light chains, b3-L variants are shown in blue, b2-L variants are shown variants in green, and b1-L variants are shown in orange). Phylogenetically matched variants are colored in red text. HC, heavy chain; LC, light chain. *Neutralization results are color-coded as follows: light red, IC 50 ≤ 0.05 μg/mL; light brown, 0.05 μg/ mL < IC 50 ≤ 0.5 μg/mL; light yellow, 0.5 μg/mL < IC 50 ≤ 5 μg/mL; light green, IC 50 > 5 μg/mL. Table S4 . Cardiolipin reactivity of reconstructed 10E8-like antibodies by pairing 454 heavy-and light-chain variants Table S5 . Athena antinuclear antigen reactivity of reconstructed 10E8-like antibodies by pairing 454 heavy-and light-chain variants 
